Richard J Battafarano
Overview
Explore the profile of Richard J Battafarano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1922
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davis R, Akst L, Allen C, Battafarano R, Born H, Bryson P, et al.
JAMA Otolaryngol Head Neck Surg
. 2025 Jan;
151(3):263-267.
PMID: 39847385
Importance: Airway stenosis is a rare but debilitating disorder that significantly degrades the quality of life in affected patients. Treatments are primarily surgical, and disease management lacks established medical therapies....
2.
Shaikh F, Lee S, White J, Zhao Y, Ferri J, Pereira G, et al.
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518082
: Preclinical and clinical data indicate that chemoradiotherapy (CRT) in combination with checkpoint inhibitors may prime an anti-tumor immunological response in esophageal cancer. However, responses to neoadjuvant therapy can vary...
3.
Kelly R, Landon B, Zaidi A, Singh D, Canzoniero J, Balan A, et al.
Nat Med
. 2024 Mar;
30(4):1023-1034.
PMID: 38504015
Gastroesophageal cancer dynamics and drivers of clinical responses with immune checkpoint inhibitors (ICI) remain poorly understood. Potential synergistic activity of dual programmed cell death protein 1 (PD-1) and lymphocyte-activation gene...
4.
Huang P, Illei P, Franklin W, Wu P, Forde P, Ashrafinia S, et al.
Cancers (Basel)
. 2022 Sep;
14(17).
PMID: 36077686
Background: Prognostic risk factors for completely resected stage IA non-small-cell lung cancers (NSCLCs) have advanced minimally over recent decades. Although several biomarkers have been found to be associated with cancer...
5.
Battafarano R
J Thorac Cardiovasc Surg
. 2022 Aug;
165(2):515-516.
PMID: 36038382
No abstract available.
6.
Friedes C, Chakrabarti T, Olson S, Prichett L, Brahmer J, Forde P, et al.
Lung Cancer
. 2021 Feb;
154:36-43.
PMID: 33611224
Background: Definitive chemoradiation with consolidative immunotherapy offers the best chance for cure in patients with unresectable, locally advanced non-small cell lung cancer (NSCLC). However, treatment-related lymphopenia (TRL) may negatively impact...
7.
Lu Z, Zou J, Li S, Topper M, Tao Y, Zhang H, et al.
Nature
. 2020 Feb;
579(7798):284-290.
PMID: 32103175
Cancer recurrence after surgery remains an unresolved clinical problem. Myeloid cells derived from bone marrow contribute to the formation of the premetastatic microenvironment, which is required for disseminating tumour cells...
8.
Sweer J, Chen M, Salimian K, Battafarano R, Durr N
J Biophotonics
. 2019 May;
12(9):e201900005.
PMID: 31056845
As the incidence of esophageal adenocarcinoma continues to rise, there is a need for improved imaging technologies with contrast to abnormal esophageal tissues. To inform the design of optical technologies...
9.
Forde P, Chaft J, Smith K, Anagnostou V, Cottrell T, Hellmann M, et al.
N Engl J Med
. 2018 Apr;
378(21):1976-1986.
PMID: 29658848
Background: Antibodies that block programmed death 1 (PD-1) protein improve survival in patients with advanced non-small-cell lung cancer (NSCLC) but have not been tested in resectable NSCLC, a condition in...
10.